Allen IC, Scull MA, Moore CB, et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza a virus through recognition of viral RNA. Immunity. 2009;30(4):556–65.
Article
CAS
PubMed
PubMed Central
Google Scholar
Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci U S A. 1990;87(15):5978–82.
Article
CAS
PubMed
PubMed Central
Google Scholar
Aoshiba K, Onizawa S, Tsuji T, Nagai A. Therapeutic effects of erythropoietin in murine models of endotoxin shock. Crit Care Med. 2009;37(3):889–98.
Article
CAS
PubMed
Google Scholar
Avula A, Nalleballe K, Narula N, et al. COVID-19 presenting as stroke. Brain Behav Immun. 2020.
Baig AM. Neurological manifestations in COVID-19 caused by SARS-CoV-2. CNS Neurosci Ther. 2020;26(5):499–501.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bartels C, Spate K, Krampe H, Ehrenreich H. Recombinant human erythropoietin: novel strategies for neuroprotective/neuro-regenerative treatment of multiple sclerosis. Ther Adv Neurol Disord. 2008;1(3):193–206.
Article
PubMed
PubMed Central
Google Scholar
Bauchner H, Fontanarosa PB. Randomized clinical trials and COVID-19: managing expectations. JAMA. 2020.
Brines M, Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci. 2005;6(6):484–94.
Article
CAS
PubMed
Google Scholar
Cao F, Tian X, Li Z, et al. Suppression of NLRP3 Inflammasome by erythropoietin via the EPOR/JAK2/STAT3 pathway contributes to attenuation of acute lung injury in mice. Front Pharmacol. 2020;11:306.
Article
PubMed
PubMed Central
Google Scholar
Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20(5):269–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Caravagna C, Soliz J. PI3K and MEK1/2 molecular pathways are involved in the erythropoietin-mediated regulation of the central respiratory command. Respir Physiol Neurobiol. 2015;206:36–40.
Article
CAS
PubMed
Google Scholar
Casadevall A, Joyner MJ, Pirofski LA. A randomized trial of convalescent plasma for COVID-19-potentially hopeful signals. JAMA. 2020.
Cuzzocrea S, Di Paola R, Mazzon E, et al. Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice. Crit Care Med. 2006;34(4):1168–77.
Article
CAS
PubMed
Google Scholar
Dale EA, Satriotomo I, Mitchell GS. Cervical spinal erythropoietin induces phrenic motor facilitation via extracellular signal-regulated protein kinase and Akt signaling. J Neurosci. 2012;32(17):5973–83.
Article
CAS
PubMed
PubMed Central
Google Scholar
Del Rio C, Malani PN. COVID-19-new insights on a rapidly changing epidemic. JAMA. 2020;323(14):1339–40.
Article
CAS
PubMed
Google Scholar
Desforges M, Le Coupanec A, Dubeau P, et al. Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Viruses. 2019;12(1).
Digicaylioglu M, Bichet S, Marti HH, et al. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci U S A. 1995;92(9):3717–20.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dube M, Le Coupanec A, Wong AHM, Rini JM, Desforges M, Talbot PJ. Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43. J Virol. 2018;92(17):e00404–18.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ehrenreich H, Fischer B, Norra C, et al. Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain. 2007a;130(Pt 10):2577–88.
Article
PubMed
Google Scholar
Ehrenreich H, Hasselblatt M, Dembowski C, et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med. 2002;8(8):495–505.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ehrenreich H, Hinze-Selch D, Stawicki S, et al. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry. 2007b;12(2):206–20.
Article
CAS
PubMed
Google Scholar
Ehrenreich H, Neubauer AP, Miskowiak K. Erythropoietin in preterm infants. N Engl J Med. 2020;382(19):1862.
Article
PubMed
Google Scholar
Ehrenreich H, Weissenborn K, Prange H, et al. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke. 2009;40(12):e647–56.
Article
CAS
PubMed
Google Scholar
Fujii T, Nakamura T, Iwamoto A. Current concepts in SARS treatment. J Infect Chemother. 2004;10(1):1–7.
Article
PubMed
PubMed Central
Google Scholar
Gandhi S, Srivastava AK, Ray U, Tripathi PP. Is the collapse of the respiratory Center in the Brain Responsible for respiratory breakdown in COVID-19 patients? ACS Chem Neurosci. 2020.
Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020.
Grasso G, Alafaci C, Ghezzi P. Is erythropoietin a worthy candidate for traumatic brain injury or are we heading the wrong way? F1000Res. 2016;5:911.
Article
PubMed
PubMed Central
CAS
Google Scholar
Grein J, Ohmagari N, Shin D, et al. Compassionate use of Remdesivir for patients with severe Covid-19. N Engl J Med. 2020.
Gross O, Moerer O, Weber M, Huber TB, Scheithauer S. COVID-19-associated nephritis: early warning for disease severity and complications? Lancet. 2020; in press.
Gu J, Gong E, Zhang B, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202(3):415–24.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gu J, Korteweg C. Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol. 2007;170(4):1136–47.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hadadi A, Mortezazadeh M, Kolahdouzan K, Alavian G. Does recombinant human erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects? J Med Virol. 2020.
Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020.
Heneka MT, McManus RM, Latz E. Inflammasome signalling in brain function and neurodegenerative disease. Nat Rev Neurosci. 2018;19(10):610–21.
Article
CAS
PubMed
Google Scholar
Heo K, Kang JK, Choi CM, Lee MS, Noh KW, Kim SB. Prophylactic effect of erythropoietin injection to prevent acute mountain sickness: an open-label randomized controlled trial. J Korean Med Sci. 2014;29(3):416–22.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ivanov K, Garanina E, Rizvanov A, Khaiboullina S. Inflammasomes as Targets for Adjuvants. Pathogens. 2020;9(4).
Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev. 1992;72(2):449–89.
Article
CAS
PubMed
Google Scholar
Jungebluth P, Holzgraefe B, Lim ML, et al. Autologous peripheral blood mononuclear cells as treatment in refractory acute respiratory distress syndrome. Respiration. 2015;90(6):481–92.
Article
CAS
PubMed
Google Scholar
Kakavas S, Demestiha T, Vasileiou P, Xanthos T. Erythropoetin as a novel agent with pleiotropic effects against acute lung injury. Eur J Clin Pharmacol. 2011;67(1):1–9.
Article
CAS
PubMed
Google Scholar
Krantz SB. Erythropoietin. Blood. 1991;77(3):419–34.
Article
CAS
PubMed
Google Scholar
Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020; In press.
Li L, Zhang W, Hu Y, et al. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial. JAMA. 2020a.
Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020b;92(6):552–5.
Article
CAS
PubMed
Google Scholar
Li YC, Bai WZ, Hirano N, et al. Neurotropic virus tracing suggests a membranous-coating-mediated mechanism for transsynaptic communication. J Comp Neurol. 2013;521(1):203–12.
Article
CAS
PubMed
Google Scholar
Liao M, Liu Y, Yuan J, et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med. 2020; In press.
Litton E, Latham P, Inman J, Luo J, Allan P. Safety and efficacy of erythropoiesis-stimulating agents in critically ill patients admitted to the intensive care unit: a systematic review and meta-analysis. Intensive Care Med. 2019;45(9):1190–9.
Article
PubMed
Google Scholar
Liu W, Zhang Q, Chen J, et al. Detection of Covid-19 in children in early January 2020 in Wuhan, China. N Engl J Med. 2020;382(14):1370–1.
Article
PubMed
PubMed Central
Google Scholar
Lo AW, Tang NL, To KF. In: Herrington CS, Douek DC, editors. How the SARS coronavirus causes disease: host or organism? vol. 208. Chichester: Wiley; 2006. p. 142–51.
Google Scholar
Lucchese G, Floel A. Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons. Autoimmun Rev. 2020;102556.
Luo B, Wang J, Liu Z, et al. Phagocyte respiratory burst activates macrophage erythropoietin signalling to promote acute inflammation resolution. Nat Commun. 2016;7:12177.
Article
PubMed
PubMed Central
Google Scholar
Lythgoe MP, Middleton P. Ongoing clinical trials for the management of the COVID-19 pandemic. Trends Pharmacol Sci. 2020.
MacRedmond R, Singhera GK, Dorscheid DR. Erythropoietin inhibits respiratory epithelial cell apoptosis in a model of acute lung injury. Eur Respir J. 2009;33(6):1403–14.
Article
CAS
PubMed
Google Scholar
Magagnoli JNA, Periera F, Cummings T, Hardin JW, Pharm SS, Ambati J. Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19. MedRxiv The preprint Server for Health Sciences. 2020.
Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020.
Marti HH, Wenger RH, Rivas LA, et al. Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci. 1996;8(4):666–76.
Article
CAS
PubMed
Google Scholar
Mehta P, Cron RQ, Hartwell J, Manson JJ, Tattersall RS. Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome. Lancet Rheumatol. 2020a.
Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020b;395(10229):1033–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mesgarpour B, Heidinger BH, Roth D, Schmitz S, Walsh CD, Herkner H. Harms of off-label erythropoiesis-stimulating agents for critically ill people. Cochrane Database Syst Rev. 2017;8(8):CD010969.
PubMed
Google Scholar
Miskowiak KW, Ehrenreich H, Christensen EM, Kessing LV, Vinberg M. Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial. J Clin Psychiatry. 2014a;75(12):1347–55.
Article
PubMed
Google Scholar
Miskowiak KW, Vinberg M, Christensen EM, et al. Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial. Neuropsychopharmacology. 2014b;39(6):1399–408.
Article
CAS
PubMed
PubMed Central
Google Scholar
Miskowiak KW, Vinberg M, Macoveanu J, et al. Effects of erythropoietin on hippocampal volume and memory in mood disorders. Biol Psychiatry. 2015;78(4):270–7.
Article
CAS
PubMed
Google Scholar
Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11(1):37.
Article
PubMed
PubMed Central
Google Scholar
Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Munster V, Feldmann F, Williamson B, et al. Respiratory disease in rhesus macaques inoculated with SARS-CoV-2. Nature. 2020; In press.
Nath A. Neurologic complications of coronavirus infections. Neurology. 2020.
Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;82(15):7264–75.
Article
CAS
PubMed
PubMed Central
Google Scholar
Oxley TJ, Mocco J, Majidi S, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020.
Ozer EA, Kumral A, Ozer E, et al. Effects of erythropoietin on hyperoxic lung injury in neonatal rats. Pediatr Res. 2005;58(1):38–41.
Article
CAS
PubMed
Google Scholar
Paranjpe I, Fuster V, Lala A, et al. Association of Treatment Dose Anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol. 2020.
Peng B, Kong G, Yang C, Ming Y. Erythropoietin and its derivatives: from tissue protection to immune regulation. Cell Death Dis. 2020;11(2):79.
Article
CAS
PubMed
PubMed Central
Google Scholar
Perico L, Benigni A, Remuzzi G. Should COVID-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockade. Nephron. 2020:1–9.
Rocha J, Eduardo-Figueira M, Barateiro A, et al. Erythropoietin reduces acute lung injury and multiple organ failure/dysfunction associated to a scald-burn inflammatory injury in the rat. Inflammation. 2015;38(1):312–26.
Article
CAS
PubMed
Google Scholar
Sakanaka M, Wen TC, Matsuda S, et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A. 1998;95(8):4635–40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA. 2020.
Sargin D, Friedrichs H, El-Kordi A, Ehrenreich H. Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research. Best Pract Res Clin Anaesthesiol. 2010;24(4):573–94.
Article
CAS
PubMed
Google Scholar
Shang Y, Li X, Prasad PV, et al. Erythropoietin attenuates lung injury in lipopolysaccharide treated rats. J Surg Res. 2009;155(1):104–10.
Article
CAS
PubMed
Google Scholar
Shingo T, Sorokan ST, Shimazaki T, Weiss S. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci. 2001;21(24):9733–43.
Article
CAS
PubMed
PubMed Central
Google Scholar
Silva CA, Vicente MC, Tenorio-Lopes L, Soliz J, Gargaglioni LH. Erythropoietin in the locus coeruleus attenuates the ventilatory response to CO2 in rats. Respir Physiol Neurobiol. 2017;236:11–8.
Article
CAS
PubMed
Google Scholar
Silver M, Corwin MJ, Bazan A, Gettinger A, Enny C, Corwin HL. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial. Crit Care Med. 2006;34(9):2310–6.
Article
CAS
PubMed
Google Scholar
Siren AL, Fasshauer T, Bartels C, Ehrenreich H. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics. 2009;6(1):108–27.
Article
CAS
PubMed
PubMed Central
Google Scholar
Soliz J, Thomsen JJ, Soulage C, Lundby C, Gassmann M. Sex-dependent regulation of hypoxic ventilation in mice and humans is mediated by erythropoietin. Am J Physiol Regul Integr Comp Physiol. 2009;296(6):R1837–46.
Article
CAS
PubMed
Google Scholar
Steardo L, Zorec R, Verkhratsky A. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19; 2020. p. e13473.
Google Scholar
Suresh S, Rajvanshi PK, Noguchi CT. The many facets of erythropoietin physiologic and metabolic response. Front Physiol. 2019;10:1534.
Article
PubMed
Google Scholar
Tascilar O, Cakmak GK, Tekin IO, et al. Protective effects of erythropoietin against acute lung injury in a rat model of acute necrotizing pancreatitis. World J Gastroenterol. 2007;13(46):6172–82.
Article
CAS
PubMed
PubMed Central
Google Scholar
Toscano G, Palmerini F, Ravaglia S, et al. Guillain-Barre syndrome associated with SARS-CoV-2. N Engl J Med. 2020.
Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain, Behav Immunity. 2020.
Wakhloo D, Scharkowski F, Curto Y, et al. Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin. Nat Commun. 2020;11(1):1313.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020b;323(11).
Wang X, Xu W, Hu G, et al. SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion. Cell Mol Immunol. 2020a.
Wen W, Su W, Tang H, et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 2020;6:31.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wincewicz D, Miskowiak KW, Vieta E. COVID-19: potential benefits of erythropoietin. (in review). 2020.
Google Scholar
Worthmann H, Martens-Lobenhoffer J, Joumaah M, et al. Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke. Stroke. 2013;44(8):2128–33.
Article
CAS
PubMed
Google Scholar
Wu H, Dong G, Liu H, Xu B, Li D, Jing H. Erythropoietin attenuates ischemia-reperfusion induced lung injury by inhibiting tumor necrosis factor-alpha and matrix metalloproteinase-9 expression. Eur J Pharmacol. 2009;602(2–3):406–12.
Article
CAS
PubMed
Google Scholar
Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020.
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020.
Wustenberg T, Begemann M, Bartels C, et al. Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia. Mol Psychiatry. 2011;16(1):26–36 21.
Article
CAS
PubMed
Google Scholar
Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020.
Yildirim E, Ozisik K, Solaroglu I, et al. Protective effect of erythropoietin on type II pneumocyte cells after traumatic brain injury in rats. J Trauma. 2005;58(6):1252–8.
Article
CAS
PubMed
Google Scholar
Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and Antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382(17):e38.
Article
PubMed
Google Scholar
Zhu M, Wang L, Yang J, et al. Erythropoietin ameliorates lung injury by accelerating pulmonary endothelium cell proliferation via Janus kinase-signal transducer and activator of transcription 3 pathway after kidney ischemia and reperfusion injury. Transplant Proc. 2019;51(3):972–8.
Article
CAS
PubMed
Google Scholar